Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers. - Manore, Sara; Zhuang, Chuling; Najjar, Mariana K.; Wong, Grace L.; Bindal, Shivani; Watabe, Kounosuke; Lin, Jiayuh; Lo, Hui-Wen (Cells (2073-4409), 2024)